Fetal and perinatal risk factors for inflammatory bowel disease

被引:27
|
作者
Aspberg, Sara [1 ]
Dahlquist, Gisela
Kahan, Thomas
Kallen, Bengt
机构
[1] Karolinska Inst, Dept Clin Sci, Danderyd Hosp, Div Internal Med, SE-18288 Stockholm, Sweden
[2] Umea Univ, Dept Clin Sci, Umea, Sweden
[3] Lund Univ, Tornblad Inst, Lund, Sweden
关键词
Crohn's disease; neonatal infection; smoking; ulcerative colitis;
D O I
10.1080/08035250600573151
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To study the influence of specific factors and events during pregnancy and the perinatal period on the risk of children developing inflammatory bowel disease. Methods: Population-based national register study. Linkage between the Swedish Medical Birth Register and the Swedish Hospital Discharge Register during the period 1987 to 2000 identified 455 singleton infants who later developed inflammatory bowel disease. Data for these children were compared with data for all children born in Sweden during the same period. Results: Smoking during early pregnancy reduced the risk of inflammatory bowel disease ( odds ratio ( OR) 0.71, 95% CI 0.55-0.91). For ulcerative colitis the odds ratio was 0.70 ( 95% CI 0.56-0.86), and for Crohn's disease 0.73 ( 95% CI 0.58 - 0.94). Infections during the neonatal period seemed to increase the risk of inflammatory bowel disease ( OR 17.6, 95% CI 3.6 - 51.6), but the number of observed events was small. The other factors examined did not influence the risk of inflammatory bowel disease. Conclusion: Maternal smoking during early pregnancy reduces the risk for the child to be hospitalized with a diagnosis of inflammatory bowel disease. Severe neonatal infections may increase the risk. Thus, some exposures during the fetal and neonatal period seem to affect the risk of inflammatory bowel disease later in life.
引用
收藏
页码:1001 / 1004
页数:4
相关论文
共 50 条
  • [31] Incidence and risk factors for neoplasia in inflammatory bowel disease
    Garcia, Joana Lemos
    Rosa, Isadora
    da Silva, Joao Pereira
    Moleiro, Joana
    Claro, Isabel
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (05) : 559 - 564
  • [32] Risk factors and management of osteoporosis in inflammatory bowel disease
    Targownik, Laura E.
    Bernstein, Charles N.
    Leslie, William D.
    CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (02) : 168 - 174
  • [33] RISK-FACTORS IN INFLAMMATORY BOWEL-DISEASE
    OMORAIN, C
    TOBIN, A
    SUZUKI, Y
    ORIORDAN, T
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1989, 24 : 58 - 60
  • [34] INCIDENCE AND RISK FACTORS FOR NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
    Garcia, Joana Lemos
    Rosa, Isadora
    Moleiro, Joana
    da Silva, Joao Pereira
    Pereira, Antonio Dias
    GASTROENTEROLOGY, 2021, 160 (03) : S58 - S59
  • [35] INCIDENCE AND RISK FACTORS FOR NEOPLASIA IN INFLAMMATORY BOWEL DISEASE
    Garcia, Joana Lemos
    Rosa, Isadora
    Moleiro, Joana
    da Silva, Joao Pereira
    Pereira, Antonio Dias
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S43 - S43
  • [36] Perinatal outcome in women with inflammatory bowel disease
    Piotr, Wozniak
    Aleksandra, Brucka-Kaczor
    Ewelina, Litwinska
    Przemyslaw, Oszukowski
    Agnieszka, Pieta-Dolinska
    GINEKOLOGIA POLSKA, 2015, 86 (05) : 376 - 382
  • [37] THE POPULATION ATTRIBUTABLE RISK OF MODIFIABLE RISK FACTORS FOR INFLAMMATORY BOWEL DISEASE
    Lopes, Emily W.
    Song, Mingyang
    Burke, Kristin E.
    Ananthakrishnan, Ashwin
    Richter, James
    Lochhead, Paul
    Chan, Andrew
    Khalili, Hamed
    GASTROENTEROLOGY, 2021, 160 (06) : S81 - S81
  • [38] RISK FACTORS FOR INCIDENT INFLAMMATORY BOWEL DISEASE ACCORDING TO DISEASE PHENOTYPE
    Lopes, Emily W.
    Burke, Kristin E.
    Richter, James
    Ananthakrishnan, Ashwin
    Lochhead, Paul
    Chan, Andrew
    Khalili, Hamed
    GASTROENTEROLOGY, 2021, 160 (06) : S528 - S528
  • [39] Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype
    Lopes, Emily W.
    Lochhead, Paul
    Burke, Kristin E.
    Richter, James M.
    Ananthakrishnan, Ashwin N.
    Chan, Andrew T.
    Khalili, Hamed
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (10) : 2347 - +
  • [40] The prevalence and risk factors for lymphoproliferative disease in patients with inflammatory bowel disease
    Chiorean, Michael V.
    Adabala, Jaya
    Helper, Debra J.
    Galetti, Bridget D.
    Musick, Beverly S.
    Calley, Cynthia S.
    GASTROENTEROLOGY, 2007, 132 (04) : A511 - A511